Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes (TILs) and residual cancer burden (RCB)

被引：0
|
作者：
Asano, Y.
Kashiwagi, S.
Goto, W.
Takada, K.
Takashima, T.
Morisaki, T.
Noda, S.
Onoda, N.
Ohsawa, M.
Hirakawa, K.
Ohira, M.
机构：
[1] Osaka City Univ, Grad Sch Med, Osaka, Japan
[2] Osaka City Univ, Grad Sch Med, Deaprtment Diagnost Pathol, Osaka, Japan
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P2-05-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-05-05
引用
收藏
页数：2
相关论文
共 50 条
  • [21] BREAST CANCER RESPONSE TO NEOADJUVANT CHEMOTHERAPY QUANTIFIED BY RESIDUAL CANCER BURDEN (RCB) SCORE
    Popa, Cristian Nicolae
    Birla, Rodica Daniela
    Dinu, Daniela Elena
    Iosif, Cristina
    Bogaseriu, Evelina
    Mates, Ioan Nicolae
    FARMACIA, 2022, 70 (04) : 712 - 719
  • [22] Tumor-infiltrating lymphocytes and response prediction to neoadjuvant chemotherapy in HER2-positive breast cancer
    Heppner, B. Ingold
    Untch, M.
    Denkert, C.
    Pfitzner, B. M.
    Lederer, B.
    Schmidt, W.
    Eidtmann, H.
    Fasching, P.
    Tesch, H.
    Solbach, C.
    Rezai, M.
    Zahm, D. -M.
    Holms, F.
    Glados, M.
    Krabisch, P.
    Heck, E.
    Ober, A.
    Lorenz, P.
    Diebold, K.
    Habeck, J.
    Loibl, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 5 - 5
  • [23] Ultrasound features combined with tumor-infiltrating lymphocytes for prediction of pathological response to neoadjuvant chemotherapy in breast cancer
    Jia, Yingying
    Zhou, Xin
    Zhu, Yangyang
    Song, Xuewen
    Duan, Ying
    Chen, Kundi
    Nie, Fang
    MEDICAL ULTRASONOGRAPHY, 2023, 25 (02) : 131 - 138
  • [24] Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer
    Kurozumi, Sasagu
    Inoue, Kenichi
    Matsumoto, Hiroshi
    Fujii, Takaaki
    Horiguchi, Jun
    Oyama, Tetsunari
    Kurosumi, Masafumi
    Shirabe, Ken
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [25] Predictive Factors of Neoadjuvant Chemotherapy Response in Breast Cancer Validated by Three Anatomopathological Scores: Residual Cancer Burden, Chevallier System, and Tumor-Infiltrating Lymphocytes
    Popa, Cristian N.
    Birla, Rodica
    Daniela, Dinu
    Iosif, Cristina
    Chirita, Evelina
    Mates, Ioan Nicolae
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [26] Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer
    Sasagu Kurozumi
    Kenichi Inoue
    Hiroshi Matsumoto
    Takaaki Fujii
    Jun Horiguchi
    Tetsunari Oyama
    Masafumi Kurosumi
    Ken Shirabe
    Scientific Reports, 9
  • [27] Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of TILs within fibrotic foci
    Kashiwagi, Shnichiro
    Asano, Yuka
    Goto, Wataru
    Takada, Koji
    Morisaki, Tamami
    Noda, Satoru
    Takashima, Tsutomu
    Onoda, Naoyoshi
    Hirakawa, Kosei
    Ohira, Masaichi
    CANCER SCIENCE, 2018, 109 : 521 - 521
  • [28] Changes in Tumor-infiltrating Lymphocytes After Neoadjuvant Chemotherapy and Clinical Significance in Triple Negative Breast Cancer
    Lee, Hyun
    Lee, Miseon
    Seo, Jeong-Han
    Gong, Gyungyub
    Lee, Hee Jin
    ANTICANCER RESEARCH, 2020, 40 (04) : 1883 - 1890
  • [29] Tumor-infiltrating lymphocytes (TILs) is associated with improved overall survival in triple-negative breast cancer (TNBC) patients treated with neoadjuvant chemotherapy (NAC)
    Sampaio, Cd D. A. T.
    de Lima, V. C. C.
    de Andrade, V. P.
    Neotti, T.
    Tavares, M. C.
    Sessa, V. A.
    Calsavara, V. F.
    Zenun, G. R.
    Giongo, A. A.
    da Costa, A. A. B. A.
    CANCER RESEARCH, 2017, 77
  • [30] Tumor-infiltrating lymphocytes (TILs)/volume and prognosis: The value of TILs for survival in HER2 and TN breast cancer patients treated with chemotherapy
    Okcu, Oguzhan
    Ozturk, Seda Duman
    Ozturk, Cigdem
    Sen, Bayram
    Yasin, Ayse Irem
    Bedir, Recep
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2022, 58
12345